W Michael Foster, PhD
Durham, North Carolina, 27710, United States
NCT Number: NCT00574158
The goals of the research are designed to accomplish genetic association studies of candidate genes in healthy normal individuals exposed to 0.2 ppm for 2.25 hours with intermittent exercise in order to search for associations between defined genotypes/haplotypes and 3 specific in vivo respiratory endpoints: a) change in FEV1 immediately after ozone exposure; b) change nonspecific bronchial reactivity as reflected in the change in methacholine PC20 FEV1 24 hours after ozone exposure ; and c) change in lung epithelial integrity as reflected in the Clearance Halftime of technetium 24 hours after ozone exposure. These studies have been carried forward to take place in 4 phases:
i) healthy individuals have been exposed to O3 using our standard exposure protocol; and we will increase the numbers of individuals available for study.
ii) perform genetic association studies for the endpoints of spirometry (FEV1, FVC, FEV1/FVC), PC20 FEV1 for methacholine, and epithelial integrity (Clearance Halftime) for 3 candidate O3 response genes taken from literature searches and/or previously characterized to demonstrate associations. These physiologic endpoints have been examined in terms of both a continuum of response, and discrete "responder" and "non-responder" endpoints.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Observational
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: acute and at 18 to 24 hour followup.
Phenotype physiologic responses to ambient level of ozone exposure.
National Institute of Environmental Health Sciences (NIEHS)
Nih
Project 2: Genetic Regulation of Ozone Induced Inflammation in Humans.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05992519
Asthma, Asthma in Children
Sherbrooke, Quebec, Canada
View Trial DetailsNCT02719899
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04117581
Asthma, Avitaminosis
Chester, Chesire, United Kingdom
View Trial DetailsNCT02360072
Asthma, Bronchial Diseases
Guangzhou, Guangdong, China
View Trial Details